Laquinimod
Laquinimod is an experimental immunomodulator developed by Active Biotech and Teva. It is currently being investigated for its potential use in treating multiple sclerosis and Huntington's disease.
Mechanism of Action[edit]
Laquinimod is believed to work by modulating the immune system, reducing inflammation and potentially even promoting neuroprotection. However, the exact mechanism of action is not fully understood.
Clinical Trials[edit]
Laquinimod has undergone several clinical trials to assess its safety and efficacy in treating multiple sclerosis and Huntington's disease.
Multiple Sclerosis[edit]
In clinical trials for multiple sclerosis, laquinimod has shown a reduction in the rate of relapse and a slowing of disease progression. However, it has not yet been approved for use in this condition.
Huntington's Disease[edit]
Clinical trials for Huntington's disease are ongoing. Preliminary results suggest that laquinimod may slow the progression of the disease, but further research is needed.
Side Effects[edit]
Common side effects of laquinimod include back pain, cough, and diarrhea. More serious side effects may include liver damage and severe allergic reactions.
See Also[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
-
Laquinimod chemical structure
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
